Clinical Trials
40 trialsINSPIRE
Singlera Genomics Inc.
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Nab-PIPAC
University Hospital, Geneva
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Qurgen Inc.
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
DCE-MRI
University Hospital, Ghent
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
VUBAR
Universitair Ziekenhuis Brussel
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
CADENCE
MiRXES Pte Ltd
WEE1
Impact Therapeutics, Inc.
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
RESTORE
Blue Note Therapeutics
Coala-T-CBD
Main Line Health
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
PIONEER
SpeciCare
OnkoFit II
University Hospital Tuebingen
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
PIPACRegis
University of Magdeburg
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
COTI2-101
Critical Outcome Technologies Inc.
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Xuanwu Hospital, Beijing
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
SPGO Research Mannheim GmbH
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
Hillel Yaffe Medical Center
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Novacea
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Julius-Maximilians University
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
Aronex Pharmaceuticals